News related to Lipitor (Atorvastatin) and/or conditions it is approved for
FDA won't accept Merck's application for new drug (AP)
Source: Y! Health Cholesterol News [2009.11.02]
AP - U.S. regulators have refused to accept drugmaker Merck & Co.'s application for a new, combination cholesterol pill that includes rival Pfizer's Lipitor, the world's top-selling drug.
Study: Cholesterol drugs may improve flu survival (AP)
Source: Y! Health Cholesterol News [2009.10.29]
AP - A new treatment for swine flu may already be on pharmacy shelves — cholesterol-lowering statin drugs like Lipitor and Zocor.
Ezetimibe Makes Atorvastatin More Efficient In Lowering Lipids In Men And Women Age 65 And Older
Source: Cholesterol News From Medical News Today [2009.10.29]
Adding ezetimibe to atorvastatin significantly boosted the attainment of lipid targets as specified by both Canadian and European guidelines in elderly patients aged 65 and older and the combination produced superior results than simply increasing the dose of atorvastatin alone, Dr. Christian Constance told the Canadian Cardiovascular Congress 2009, co-hosted by the Heart and Stroke Foundation and the Canadian Cardiovascular Society.
LIVALO(R) Demonstrates Sustained, Long-Term Efficacy And Tolerability In Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia
Source: Cholesterol News From Medical News Today [2009.09.02]
New data presented showed that in patients treated with LIVALO (pitavastatin), high-density lipoprotein cholesterol (HDL-C) concentrations increased, and nearly three-fourths of patients attained low-density lipoprotein cholesterol (LDL-C) targets, with results sustained over 52 weeks. Additionally, LIVALO was found to have comparable efficacy to atorvastatin and simvastatin, as measured by reduction in LDL-C from baseline.
|
